НЕВРОЛОГИЧЕСКИЕ НАРУШЕНИЯ ПОСЛЕ COVID-19: ПОСТКОВИДНЫЙ СИНДРОМ ИЛИ «ДОЛГИЙ КОВИД» ИЛИ ПОСТОСТРЫЕ ПОСЛЕДСТВИЯ COVID-19?
Ключевые слова:
постковидный синдром, «долгий ковид», неврологические проявления, постковидная усталость, когнитивные нарушенияАннотация
В статье приведены обзор литературы по проблеме постковидного синдрома, в частности, его неврологических проявлений. Частота выявляемости этих нарушений у больных после Ковид-19 по литературным данным варьирует от 2,3% до 89%, длящиеся до 8 месяцев и имеющие у части больных волнообразное течение. По приведенным противоречивым данным в статье обнажаются нерешенные проблемы по терминологии, классификации, патогенеза, частоты встречаемости и лечении постковидного синдрома.
Библиографические ссылки
Frontera J.A., Lewis A., Melmed K. et al. Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States. Front Aging Neurosci. 2021;13:690383. DOI: 10.3389/fnagi.2021.690383.
Townsend L., Dyer A., Jones K. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. DOI: 10.1371/journal.pone.0240784.
COVID-19 rapid guideline: managing the long-term effects of COVID-19: [англ.]: Overview. - UK: National Institute for Health and Care Excellence, 2020. - 18 December.
Long-Term Effects of COVID-19: [англ.]. - USA: Centers for Disease Control and Prevention, 2020. - 13 November.
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App (англ.) // preprints from medRxiv : 2020. 21 October.
Katie McCallum. Post-COVID Syndrome: What Should You Do If You Have Lingering COVID-19 Symptoms? (англ.).
Долгий COVID-19 // ФГБОУ ДПО "Российская медицинская академия непрерывного профессионального образования" Минздрава России, Москва, Россия.
Perego E, 2020. Available at: https://twitter.com/elisaperego78/status/ 1263172084055838721?s=20. Accessed: 31.07.2020.].
Keay L. Long-term COVID Warning: ICU Doctor Reports Having Coronavirus Symptoms for Three Months. Available at: https://news.sky.com/ story/long-term-covid-warning-icu-doctor-reports-having-coronavirus-symptoms-for-three-months-12014361. Accessed: 19.08.2020.
Mahase E. Covid-19: what Do We Know about “Long Covid”? BMJ. 2020; 370.DOI: 10.1136/bmj.m2815.
Белоцерковская Ю.Г., Романовских А.Г., Смирнов И.П., Синопальников А.И. Долгий COVID-19. Consilium Medicum. 2021; 23 (3): 261–268. DOI: 10.26442/20751753.2021.3.200805.
Elaine Maxwell, Content Lead, NIHR CED, with Ruth Poole, Living with Covid19 – Second review Published on 16 March 2021 doi: 10.3310/ themedreview_45225
Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., et al. (2020) *PRE PRINT* Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. medRxiv. https://www.medrxiv.org/content/10.1101/ 2020.12.24.20 248802v2.full
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., et al. (2021) *PREPRINT* Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv. https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1
Cirulli, E., Barrett, K.M.S., Riffle, S., Bolze, A., Neveux, I., et al. (2020) *PRE PRINT* Long-term COVID-19 symptoms in a large unselected population. medrxiv. https://www.medrxiv.org/content/10.1101/2020.10.07.20208702v3.full-text
Amenta, E.M., Spallone, A., Rodriguez-Barradas, M.C., El Sahly, H.M., Atmar, R.L. and Kulkarni, P.A., (2020) December. Postacute COVID-19: An Overview and Approach to Classification. Open forum infectious diseases (Vol. 7, No. 12, p. ofaa509)
Ceravolo, M.G., Arienti, C., De Sire, A., Andrenelli, E., Negrini, F., et al. (2020) Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med, pp.642-651.
Salmon-Ceron, D., Slama, D., De Broucker, T., Karmochkine, M., Pavie, J., et al. (2020) Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. The Journal of infection.
Tenforde, M.W., Kim, S.S., Lindsell, C.J., Rose, E.B., Shapiro, N.I., et al. (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March–June 2020. Morbidity and Mortality Weekly Report, 69(30), p.993.
D'Cruz, R.F., Waller, M.D., Perrin, F., Periselneris, J., Norton, S., et al. (2020). Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Research.
Halpin, S.J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., et al. (2021) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. Journal of medical virology, 93(2), pp.1013-1022.
Carfì, A., Bernabei, R. and Landi, F. (2020). Persistent symptoms in patients after acute COVID-19. Jama, 324(6), pp.603-605.
Tomasoni, D., Bai, F., Castoldi, R., Barbanotti, D., Falcinella, C., et al. (2021). Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. Journal of Medical Virology, 93(2), pp.1175-1179.
Moreno-Pérez, O., Merino, E., Leon-Ramirez, J.M., Andres, M., Ramos, J.M., et al. (2021) Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. Journal of Infection.
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., et al. (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet.
Logue, J.K., Franko, N.M., McCulloch, D.J., McDonald, D., Magedson, A., et al. (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Network Open 4(2), pp.e210830-e210830.
Munblit, D., Bobkova, P., Spiridonova, E., Shikhaleva, A., Gamirova, A., et al. (2021) *PRE PRINT* Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study. medRxiv.
Fauci Introduces New Acronym for Long COVID at White House Briefing. Medscape (Electronic resourсe.) URL: https://www.medscape.com/viewarticle/ 946419.
Официальная обновляемая русскоязычная онлайн-версия МКБ-10.
The Effects of COVID-19 on Hypothalamus: Is it Another Face of SARS-CoV-2 That May Potentially Control the Level of COVID-19 Severity?
Dr. Andrew White. A Tale of Two Syndromes – POTS and MCAS (англ.).
SH. I. Nasritdinova D. K. Xaydarova Peculiarities of the Neurological Status of Pregnant Women and Parents Infected with Covid-19 During Different Times of Gestation. Central asian journal of medical and natural sciences. Volume: 02. 2021. Р. 182-18833.
Wildwing, T. and Holt, N. (2021) The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services. Therapeutic Advances in Chronic Disease, 12, p.2040622320976979.
Hui DS, Wong KT, Antonio GE, et al. Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med J. 2009; 15 (Suppl. 8): 21–3. Available at: https://pubmed.ncbi.nlm.nih.gov/ 20393208/ Accessed: 11.05.2020].
Lam MH-B, Wing Y-K, Yu MW-M, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009; 169: 2142–7. DOI: 10.1001/archinternmed.2009.384.
Rudroff T., Fietsam A.C., Deters J.R. et al. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci. 2020;10(12):1012. DOI: 10.3390/brainsci10121012.
Larsen N.W., Stiles L.E., Miglis M.G. Preparing for the long-haul: Autonomic complications of COVID-19. Auton Neurosci. 2021;235:102841. DOI: 10.1016/j.autneu.2021.102841.
Lopez-Leon S., Wegman-Ostrosky T., Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. DOI: 10.1038/s41598-021-95565-8.
Stavem K., Ghanima W., Olsen M.K. et al. Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study. Int J Environ Res Public Health. 2021;18(4):2030. DOI: 10.3390/ijerph18042030.
Willi S., Lüthold R., Hunt A. et al. COVID-19 sequelae in adults aged less than 50 years: A systematic review. Travel Med Infect Dis. 2021;40:101995. DOI: 10.1016/j.tmaid.2021.101995.
Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. DOI: 10.1186/1471-2377-11-37.
Tansey C.M., Louie M., Loeb M. et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Int. Med. 2007;167(12):1312–1320. DOI: 10.1001/archinte.167.12.1312.
Carfì A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603.
Fukuda K., Straus S.E., Hickie I. et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(11):953–959. DOI: 10.7326/0003-4819-121-12-199412150-00009.
Dahm T, Rudolph H, Schwerk C, et al. Neuroinvasion and inflammationin viral central nervous system infections. Mediators Inflamm. 2016; 2016: 8562805. DOI: 10.1155/2016/8562805
Chen G., Wu D., Guo W. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. DOI: 10.1172/JCI137244.
Abenza-Abildúa M.J., Novo-Aparicio S., Moreno-Zabaleta R. et al. Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious? Int J Infect Dis. 2020;98:398–400.
Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M. et al. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. DOI: 10.1016/j.cytogfr.2020.06.001.
Baig, A.M., (2020) Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS chemical neuroscience.
Eric Y. Wang, Tianyang Mao, Jon Klein, Yile Dai, John D. Huck. Diverse Functional Autoantibodies in Patients with COVID-19 // medRxiv, 2020;12(12). - doi:10.1101/2020.12.10.20247205.
Yu Zuo, Shanea K. Estes, Ramadan A. Ali, Alex A. Gandhi, Srilakshmi Yalavarthi. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 // Science Translational Medicine, 2020; 2(570): - ISSN 1946-6242. doi:10.1126/scitranslmed.abd3876.
Yu. A. Desheva, A. S. Mamontov, P. G. Nazarov. Contribution of antibody-dependent enhancement to the pathogenesis of coronavirus infections // AIMS Allergy and Immunology, 2020; 4(3):50–59.
Yu. D. Nechipurenko, A.A. Anashkina, O. V. Matveeva. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm // Biophysics, 2020; 65(4):703–709. – ISSN 0006-3509.
Raman, B., Cassar, M.P., Tunnicliffe, E.M., Filippini, N., Griffanti, L., et al. (2021). Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine, 31, p.100683.
Guedj, E., Campion, J.Y., Dudouet, P. et al. (2021) 18F-FDG brain PET hypometabolism in patients with Long COVID. Eur J Nucl Med Mol Imaging.
